Order Article Reprints

Sowa-Staszczak A, Opalińska M, Kurzyńska A, Morawiec-Sławek K, Gilis-Januszewska A, Palen-Tytko J, Olearska H, Hubalewska-Dydejczyk A. Self-Administration of Long-Acting Somatostatin Analogues in NET Patients—Does It Affect the Clinical Outcome? Medicina. 2021; 57(12):1287. https://doi.org/10.3390/medicina57121287

Sowa-Staszczak, Anna, Marta Opalińska, Anna Kurzyńska, Karolina Morawiec-Sławek, Aleksandra Gilis-Januszewska, Joanna Palen-Tytko, Helena Olearska, and Alicja Hubalewska-Dydejczyk. 2021. "Self-Administration of Long-Acting Somatostatin Analogues in NET Patients—Does It Affect the Clinical Outcome?" Medicina 57, no. 12: 1287. https://doi.org/10.3390/medicina57121287

Sowa-Staszczak, A., Opalińska, M., Kurzyńska, A., Morawiec-Sławek, K., Gilis-Januszewska, A., Palen-Tytko, J., Olearska, H., & Hubalewska-Dydejczyk, A. (2021). Self-Administration of Long-Acting Somatostatin Analogues in NET Patients—Does It Affect the Clinical Outcome? Medicina, 57(12), 1287. https://doi.org/10.3390/medicina57121287